Team of clinical researchers reviewing trial data and recovery plans, representing a clinical trial rescue scenario.
Clinical Trial Rescue: How to Spot Trouble and Act Fast Even the most carefully designed clinical trials can falter. Whether due to operational breakdowns, poor enrollment, or misaligned CRO performance, a promising study can suddenly veer off course. That’s when a clinical trial rescue becomes not just an option — but a necessity.  In this article, we explore what a clinical trial rescue entails, how Read more
Clinical Research Focus 42nd edition | Cromos Pharma | EMA Recommends Conditional Approval of Zemcelpro for Blood Cancer Patients Lacking Donors
Clinical Research Focus. 42nd Edition EMA Recommends Conditional Approval of Zemcelpro for Blood Cancer Patients Lacking Donors The EMA has recommended conditional marketing authorisation for Zemcelpro, a novel stem cell therapy developed to support patients with blood cancers who require a stem cell transplant but lack a suitable donor. By expanding umbilical cord blood cells, Zemcelpro aims to improve engraftment Read more
BIO 2025 Key takeaways
Key Takeaways from BIO 2025: What’s Next for Biotech and Clinical Trials What’s next for biotech? If you walked the halls of BIO 2025 in Boston, the answer was everywhere—in AI-driven drug development, smarter clinical trial strategies, and a renewed focus on execution over hype. Cromos Pharma’s Business Development Director, Nicole Brenna, was on the ground meeting partners and tracking the trends that are shaping the future Read more
Rescuing Failing Cancer Trials with the Right Oncology CRO Discover why oncology trials fail and how the right oncology CRO can step in to rescue struggling studies, improve enrollment, and stabilize operations. Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us